Mylan Gets Summary Judgment Against Sanofi Antitrust Claims In EpiPen MDL
KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on Dec. 17 granted summary judgment against Sanofi-Aventis US LLC in its antitrust claim against EpiPen maker Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article